Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) — Free Cash Flow Generation Index
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) has a Free Cash Flow Generation Index of 0.87x as of September 2025. Free cash flow of $103.40 Million represents 1% of operating cash flow ($118.45 Million). See AMRX net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Amneal Pharmaceuticals, Inc. Class A Common Stock Free Cash Flow Generation Index (2014–2024)
Historical FCF Generation Index trend for Amneal Pharmaceuticals, Inc. Class A Common Stock across 11 annual periods. Explore AMRX debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Amneal Pharmaceuticals, Inc. Class A Common Stock (2014–2024)
Year-by-year Free Cash Flow Generation Index for Amneal Pharmaceuticals, Inc. Class A Common Stock. For the full company profile including market capitalisation, see Amneal Pharmaceuticals, Inc. Class A Com stock valuation.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.82x | $243.18 Million | $295.10 Million | $51.92 Million | ▲ +3.0% |
| 2023 | 0.80x | $276.39 Million | $345.58 Million | $69.19 Million | ▲ +304.2% |
| 2022 | -0.39x | $-25.50 Million | $65.10 Million | $90.59 Million | ▼ -150.1% |
| 2021 | 0.78x | $189.18 Million | $241.82 Million | $52.64 Million | ▼ -5.2% |
| 2020 | 0.83x | $312.81 Million | $379.00 Million | $66.19 Million | ▲ +101.5% |
| 2019 | -56.14x | $-95.73 Million | $1.71 Million | $97.43 Million | ▼ -9273.8% |
| 2018 | 0.61x | $153.14 Million | $250.23 Million | $97.09 Million | ▲ +19.5% |
| 2017 | 0.51x | $119.92 Million | $234.19 Million | $114.27 Million | ▲ +717.2% |
| 2016 | -0.08x | $-9.55 Million | $115.06 Million | $124.61 Million | ▲ +30.4% |
| 2015 | -0.12x | $-12.50 Million | $104.88 Million | $117.38 Million | ▼ -140.7% |
| 2014 | 0.29x | $32.87 Million | $112.26 Million | $79.38 Million | — |